Texas’ $50M ibogaine match unmet; feds offer to fill gap
Texas reserved $50 million for ibogaine clinical trials on the condition that another party match the funding; no qualifying proposal was submitted and federal officials have offered to match state investments instead.
Texas set aside $50 million to support clinical trials of the psychoactive drug ibogaine, contingent on a matching proposal. No drug company submitted a qualifying proposal, and the federal government has offered to match the state’s investment instead.